Classification CIB

Détention brevets de la classe A61P 31/14

131	236	333	359	1433	1675	2033	1349	904	142
2017	2018	2019	2020	2021	2022	2023	2024	2025	2026

Proprétaire	Total	Cette classe
Gilead Sciences, Inc.	2157	138
The Regents of the University of California	20447	104
The United States of America, as represented by the Secretary, Department of Health and Human Services	2958	104
Centre National de La Recherche Scientifique	10830	85
Bristol-myers Squibb Company	4793	81
Katholieke Universiteit Leuven	1241	73
Emory University	1691	66
Enanta Pharmaceuticals, Inc.	433	65
Modernatx, Inc.	1288	65
Janssen Pharmaceuticals, Inc.	437	64
Inserm (institut National de La Sante et de La Recherche Medicale)	3352	57
Vanderbilt University	1958	54
BioNTech SE	766	53
The Trustees of the University of Pennsylvania	4396	52
Board of Regents, The University of Texas System	6028	51
Pfizer Inc.	3377	50
Shanghai Institute of Materia Medica, Chinese Academy of Sciences	854	50
Institut Pasteur	796	48
Institut National de La Sante et de La Recherche Medicale (inserm)	3102	47
The Board of Trustees of the Leland Stanford Junior University	6597	46
Autres propriétaires		11276